Invesco India Pharma and Healthcare Fund

Regular
Direct

1 Year Absolute Returns

-

NAV (₹) on 11 Sep 2026

9.99

1 Day NAV Change

-0.20%

Risk Level

Very High Risk

Rating

-

Invesco India Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by Invesco Asset Management (India) Private Limited. Launched on 18 Aug 2026, investors can start ... Read more

NAV History

Fund Details

Min. SIP Amount
₹100
Inception Date
18 Aug 2026
Min. Lumpsum Amount
₹ 1,000
Fund Age
0 Yrs
AUM
₹ 0 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
%
Scheme Type
Open Ended
Exit Load
0.5%

Returns

Annualised returns
9M 1Y 2Y 3Y
Fund returns - - - -
Category returns 5.65% 5.83% 4.91% 20.14%

Fund Objective

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance ... Read more

AMC Details

Name
Invesco Asset Management (India) Private Limited
Date of Incorporation
24 Jul 2006
CEO
Mr. Saurabh Nanavati
CIO
Mr. Taher Badshah
Type
Foreign
Address
Unit No: 2101 A, 21st floor, A - Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra, India - 400013
Website
http://www.invescomutualfund.com

Top Funds from Equity - Sectoral/Thematic

Scheme Name
NAV
Returns
1Y 3Y 5Y
AUM (Cr)
Expense Ratio
Risk Meter
Nippon India Taiwan Equity fund - Direct Plan
Sector Direct
114.25% 314.64% 0.00% ₹1,128 1.24%
Very High
Nippon India Taiwan Equity fund - Direct Plan
Sector Direct
114.25% 314.64% 0.00% ₹1,128 1.24%
Very High
Nippon India Taiwan Equity fund - Direct Plan
Sector Direct
114.25% 314.64% 0.00% ₹1,128 1.24%
Very High
Nippon India Taiwan Equity Fund
Sector Regular
111.39% 297.88% 0.00% ₹1,128 2.53%
Very High
Nippon India Taiwan Equity Fund
Sector Regular
111.39% 297.88% 0.00% ₹1,128 2.53%
Very High
Nippon India Taiwan Equity Fund
Sector Regular
111.39% 297.88% 0.00% ₹1,128 2.53%
Very High
HDFC Defence Fund - Direct Plan
Sector Direct
31.47% 152.50% 0.00% ₹11,478 0.90%
Very High
HDFC Defence Fund - Direct Plan
Sector Direct
31.47% 152.50% 0.00% ₹11,478 0.90%
Very High
HDFC Defence Fund - Direct Plan
Sector Direct
31.47% 152.50% 0.00% ₹11,478 0.90%
Very High
HDFC Defence Fund
Sector Regular
30.19% 144.38% 0.00% ₹11,478 1.79%
Very High

Top Funds from Invesco Asset Management (India) Private Limited

Scheme Name
NAV
Returns
1Y 3Y 5Y
AUM (Cr)
Expense Ratio
Risk Meter
Invesco India Gold ETF Fund of Fund - Direct Plan
Fund of Funds Direct
38.06% 147.45% 205.42% ₹463 0.11%
High
Invesco India Gold ETF Fund of Fund - Direct Plan
Fund of Funds Direct
38.06% 147.45% 205.39% ₹463 0.11%
High
Invesco India Gold ETF Fund of Fund - Direct Plan
Fund of Funds Direct
38.06% 147.45% 205.39% ₹463 0.11%
High
Invesco India Gold ETF Fund of Fund
Fund of Funds Regular
37.52% 145.30% 200.71% ₹463 0.55%
High
Invesco India Gold ETF Fund of Fund
Fund of Funds Regular
37.52% 145.30% 200.70% ₹463 0.55%
High
Invesco India Gold ETF Fund of Fund
Fund of Funds Regular
37.52% 145.30% 200.70% ₹463 0.55%
High
Invesco India - Invesco EQQQ Nasdaq-100 ETF Fund of Fund...
Fund of Funds Direct
32.28% 120.39% 0.00% ₹451 0.47%
Very High
Invesco India - Invesco EQQQ Nasdaq-100 ETF Fund of Fund
Fund of Funds Regular
31.98% 118.89% 0.00% ₹451 0.69%
Very High
Invesco India Midcap Fund - Direct Plan
Diversified Direct
10.41% 85.81% 149.84% ₹14,721 0.74%
Very High
Invesco India - Invesco Global Equity Income Fund of Fund...
International/ Global Direct
20.95% 84.48% 122.52% ₹308 0.81%
Very High

FAQs

What is the current NAV of Invesco India Pharma and Healthcare Fund Regular Growth?

The current Net Asset Value (NAV) of Invesco India Pharma and Healthcare Fund Regular Growth is ₹9.99 as of 11 Sep 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What are the historical returns of Invesco India Pharma and Healthcare Fund Regular Growth?

Invesco India Pharma and Healthcare Fund Regular Growth has delivered returns of 0.00% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of Invesco India Pharma and Healthcare Fund Regular Growth?

Invesco India Pharma and Healthcare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for Invesco India Pharma and Healthcare Fund Regular Growth?

The minimum lumpsum investment required for Invesco India Pharma and Healthcare Fund Regular Growth is ₹1,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+